Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Signal Transduct Target Ther · 2026 · PMC13009370 · PMID 41872138

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

When evaluating both OS and PFS, we observed a clear trend that patients with baseline responses to both TGFβ-15 and TGFβ-33 above the median had better outcomes than the other groups (Fig. 3 e, f).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.